Elena Gitelson Tahseen Al-Saleem Valentin Robu Michael M Millenson Mitchell R Smith
10.3109/10428190903349670
Leuk Lymphoma
2010 Jan;51(1):89-94.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/19863176/
Lymphoma, B-Cell, Marginal Zone / diagnosis Medical Oncology / methods
Lymphoma, B-Cell, Marginal Zone / diagnosis Medical Oncology / methods Case Reports Adolescent Adult Antibodies, Monoclonal / therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents / therapeutic use Flow Cytometry / methods Humans Immunophenotyping Immunotherapy / methods Lymphatic Diseases / diagnosis Lymphatic Diseases / pathology Lymphoma, B-Cell, Marginal Zone / immunology Lymphoma, B-Cell, Marginal Zone / surgery Lymphoma, B-Cell, Marginal Zone / therapy Male Prognosis Remission Induction Rituximab Treatment Outcome Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents Rituximab
PMC3572776
19863176
Pediatric nodal marginal zone lymphoma may develop in the adult population
2010